Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma

Authors :: Khadega A. Abuelgasim
Ahmed Alaskar
Moussab Damlaj
Bader Alahmari
Mohsen Alzahrani
Ayman Alhejazi
Source :: Bone Marrow Transplantation. 55:2322-2325
Publication Year :: 2020
Publisher :: Springer Science and Business Media LLC, 2020.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
business.industry
medicine.medical_treatment
Hematology
Hematopoietic stem cell transplantation
Internal medicine
Relapsed refractory
medicine
Classical Hodgkin lymphoma
Brentuximab vedotin
business
medicine.drug

Tools